By using an in vitro model, the importance of ERK1/2 in mediating GPR30 protection against TAC-induced cardiac fibrosis was verified by ERK1/2 signaling inhibitor PD98059. The gene discussed is GPER1; the disease is persistent truncus arteriosus.